Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularSTU:LHU +0.73%98 Days Inventory is 268.62 as of Jun. 2026, which is 2% below its 10-year median of 275.46. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €81.33 (Modestly Undervalued). Among 787 Medical Devices & Instruments companies, LeMaitre Vascular ranks worse than 80.56% on this metric.
The historical rank and industry rank for LeMaitre Vascular's Days Inventory or its related term are showing as below:
STU:LHU'
s Days Inventory Range Over the Past 10 Years
Min: 218.88 Med: 275.46 Max: 300.96
Current: 297.99
During the past 13 years, LeMaitre Vascular's highest Days Inventory was 300.96. The lowest was 218.88. And the median was 275.46.
STU:LHU's Days Inventory is ranked worse than 80.56% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 178.92
vs STU:LHU: 297.99
LeMaitre Vascular's Days Inventory
declined
from Jun. 2025 (277.59) to Jun. 2026 (268.62).
Inventory Turnover measures how fast the company turns over its inventory within a year.
LeMaitre Vascular's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LeMaitre Vascular's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.82.
LeMaitre Vascular (STU:LHU) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
LeMaitre Vascular's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LeMaitre Vascular's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
LeMaitre Vascular Days Inventory Related Terms
LeMaitre Vascular Days Inventory Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LHU vs PLSE, XRAY, ATRC: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Days Inventory distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (STU:LHU) has a Days Inventory of 268.62 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LeMaitre Vascular and its competitors. This is near median its historical median of 275.46. Over the past decade, LeMaitre Vascular's Days Inventory has ranged from 218.88 to 300.96. According to the industry distribution chart, LeMaitre Vascular ranks #634 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 80.6%.
Is LeMaitre Vascular's Days Inventory too high?
LeMaitre Vascular's current Days Inventory of 268.62 is near median its 10-year median of 275.46. Over the past 10 years, this metric has ranged from a low of 218.88 to a high of 300.96. The Medical Devices & Instruments industry median Days Inventory is 178.92. LeMaitre Vascular's value of 268.62 is 50.1% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #634 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Days Inventory compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #634 out of 787 companies for Days Inventory. This places LeMaitre Vascular in the lower half of its industry. The industry median Days Inventory is 178.92. LeMaitre Vascular's value of 268.62 is 50.1% above this benchmark. Historically, LeMaitre Vascular's own Days Inventory has ranged from 218.88 to 300.96 over the past decade. While the company's 10-year median is 275.46 vs. the industry median of 178.92, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 178.92, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current Days Inventory of 268.62 is 50.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 178.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current Days Inventory is 268.62, which is near median its own 10-year median of 275.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.33, compared to a current price of €69.00 — trading 15.2% below its estimated fair value. The current Days Inventory is 268.62, which is near median its 10-year median of 275.46 and 50.1% above the Medical Devices & Instruments industry median of 178.92. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current Days Inventory is 268.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of €69.00 is trading 15.2% below its estimated GF Value™ of €81.33.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for STU:LHU:
Days Inventory: 268.62 (near median its 10-year median of 275.46)
GF Value™: €81.33 vs. price of €69.00 (15.2% below fair value)
Industry Position: 50.1% above the Medical Devices & Instruments median (#634 of 787)
No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score
Get the complete analysis for STU:LHU
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LHU has been successfully added to your 
